Digital Health and BioInformatics Consulting
Medical Technology, Biotech and Payer Firms
Staying ahead of the curve to meet shareholders mandates is not easy. This is more pronounced in 2018 as health care becomes more vertically integrated to drive economies of scale. ChalkImpact Global is on an impact driven mission to enable healthcare organizations innovate on digital health products while navigating pricing and costs pressures in the industry. Whether you are a health care payer, medical technology vendor, or biotech company, let us help you.
Navigating ever changing FDA regulation, pricing, costs and competitive pressures in the industry is cumbersome. Our Principal Consultant, Chaney Ojinnaka has navigated such challenges for dozens of organizations. A corporate intrapreneur and health care expert, he has built new ventures, products and services for some of the most innovative health and wellness organizations globally. His particular area of expertise addresses how organizations can adapt to changes in payer reimbursement models, methods to integrating 4.0 technologies such as AI, IOT and blockchain and reacting to patient consumerism in benefits designs and chronic care management programs such as remote monitoring, personalized medicine and prescription drug benefits. He has over a decade of experience in clinical product innovation and large group benefit sales at firms such as Aetna and Humana. With an MBA from the University of Chicago, and an MPH from King's College London he is a frequent speaker at industry forums and academic institutions such as King's College London, Chicago Booth, and the European Forum and has published numerous white papers and opinion articles in leading publications.
Process and Outcomes Evaluation
Evaluating success of existing programs in place to determine future direction can be challenging especially considering big data advances. We have done multiple quality, cost and process evaluations for programs in areas such as weight management, home health, telemedicine, diabetes, health disparities and occupational health. We have worked with payers and systems such as Humana, BCBS, the UK National Health Service, King’s College London Hospital.
M&A Advisory and Partnerships Business Development
In today’s hyper competitive market, M&A and integrated partnerships is a great way to get ahead. With so many digital health new entrants in the last five years, filtering through the landscape is one challenge while getting the most promising partners to the negotiating table is another feat. Most challenging is figuring out what a deal looks like to incentive your partner and capture the most value - is it revenue share, a minority investment, joint venture or acquisition. We have advised companies such as Aetna, Athenahealth, Humana, XL Health.
Market Expansion and New Product Development
With ever stringent FDA regulation and vertical integration taking place among the largest payers and health systems, exploring new business models is one sure way to survive. Guided by market research and outcomes data on what works, we’ll sit with your strategy team and review your product ideas, identifying and assessing quick win products considering existing resources. We have worked with medical technology and biotech firms such as ResMed, MySugr, Klara.